Latest Financials News

Ryman Healthcare has launched a NZ$100 million fixed rate bond offer maturing in 2032, aiming to refinance existing debt and diversify its funding sources. The offer includes an exchange mechanism for existing bondholders, with trading in current bonds to be suspended during the transition.

Bounty Oil & Gas NL has issued a prospectus offering over 632 million new options to eligible investors as part of a broader recapitalisation, potentially raising $6.3 million if exercised.

Brazilian Rare Earths Limited (BRE) is demerging its Amargosa Bauxite-Gallium Project into Alurion Resources, with eligible shareholders receiving in-specie shares and access to a $30-50 million IPO.

S&P Dow Jones Indices has announced its June 2026 quarterly rebalance of the S&P/ASX indices, with ALS Limited entering the ASX 50 and several notable changes across the ASX 100 and 200 indices effective June 22.

FirstWave Cloud Technology acknowledged the material nature of cash and revenue figures disclosed during a shareholder webinar and affirmed compliance with ASX continuous disclosure rules, while committing to improved timing of market announcements.

Sandon Capital Investments plans monthly fully franked dividends of 0.47 cents per share for July to September 2026, sustaining an annualised yield of 7.2%. The company’s robust profit reserves and franking credits provide a strong buffer for dividend payments.

Boresight Ltd (ASX: BST) is seeking to raise $8 million through a public offer to expand its cost-effective military drone manufacturing, targeting growth in the US and European markets.

Ozz Resources aims to raise up to AUD 5 million through a public offer to fund the acquisition of Sulphide Minerals and exploration of the Bedaburra Project, pending ASX re-admission and shareholder approval.

SPC Global has finalised its $100 million entitlement offer, allocating most shortfall shares to sub-underwriters and positioning the company to reduce debt and support growth.

Mayne Pharma has received $14.4 million from Cosette Pharmaceuticals covering legal costs and interest following a Supreme Court ruling in its favour. The legal battle continues with Cosette’s appeal decision pending.

Microba Life Sciences has voluntarily suspended trading of its shares from 5 June 2026, ahead of a material capital raise and an update on its path to break even, expected by 11 June.

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.